Riskpilot← Back to searchSign inGet full accessDandon Medcare AB
ABActiveOrg 5590529284Östra Tullgatan 3General medical practice activities · NACE 8621Est. 20160 employees
Revenue 2025
SEK 317K
+10% vs 2024
EBITDA margin
30.9%
+1% vs 2024
Equity ratio
63.5%
Financial strength
Net profit 2025
SEK 76K
+1% vs 2024
| Revenue | SEK 317K | +10% |
| EBITDA | SEK 98K | +1% |
| Net profit | SEK 76K | +1% |
| Total assets | SEK 244K | +13% |
| Equity | SEK 155K | +19% |
| Employees | 0 | — |
Legal name
Dandon Medcare AB
Org number
5590529284
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
29 februari 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkartjänster, handel med medicinska produkter och utrustning, utbildning inom medicin samt konsult- tjänster inom medicin och medicinska behandlingar och därmed förenlig verksamhet.
Address
Östra Tullgatan 3
Email
ghena7@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 489 | 209 | 388 | 289 | 317 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 278 | 75 | 140 | 97 | 98 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 278 | 75 | 140 | 97 | 98 |
| Net financials | — | — | −1 | −1 | 1 |
| Profit before tax | 278 | 75 | 138 | 96 | 98 |
| Tax | −59 | −16 | −29 | −21 | −22 |
| Net profit | 219 | 59 | 109 | 75 | 76 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 518 | 317 | 279 | 216 | 244 |
| Equity | 301 | 180 | 164 | 130 | 155 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 217 | 137 | 115 | 86 | 89 |
| Total debt | 217 | 137 | 115 | 86 | 89 |
EBITDA margin
30.9%
This company
15.8%
Market median
+96% vs market
20212025
Equity ratio
63.5%
This company
38.2%
Market median
+66% vs market
20212025
Return on equity
49.0%
This company
18.4%
Market median
+166% vs market
20212025
Net profit margin
24.0%
This company
8.1%
Market median
+196% vs market
20212025
Asset turnover
1.30×
This company
1.12×
Market median
+16% vs market
20212025
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dandon Medcare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nagham Mahmoud | Deputy Board Member | 0 companies |
| Ghena Jahia Hatam Shabana | Board of Directors | 0 companies |
| Rami Al-Sudani | Deputy Board Member | 0 companies |